Humacyte, Inc.
HUMA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary
5 Item 1A. Risk Factors 62 Item 1B. Unresolved Staff Comments 104 Item 1C. Cybersecurity 104 Item 2. Properties 105 Item 3. Legal Proceedings 105 Item 4. Mine Safety Disclosures 106 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 107 Item 6. [Reserved] 107 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 108 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...
Next Earnings
Q2 FY2026 — expected 2026-09-14
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | HUMA | discussed_in_filing Cybersecurity | |
| topic_mention | HUMA | discussed_in_filing Cybersecurity | |
| topic_mention | HUMA | discussed_in_filing Cybersecurity | |
| topic_mention | HUMA | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-27 | 2025-12-31 | 0001818382-26-000004 | EDGAR | 121K words |
| 2025-03-31 | 2024-12-31 | 0001818382-25-000034 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001818382-24-000040 | EDGAR | — |
| 2023-03-24 | 2022-12-31 | 0001818382-23-000016 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001818382-22-000011 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0001213900-21-009571 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-12 | 2025-09-30 | 0001818382-25-000132 | EDGAR | 37K words |
| 2025-08-11 | 2025-06-30 | 0001818382-25-000125 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001818382-25-000076 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001818382-24-000199 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001818382-24-000156 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001818382-24-000056 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001818382-23-000162 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001818382-23-000114 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001818382-23-000030 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001818382-22-000180 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001818382-22-000105 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001818382-22-000039 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-19 | 0001104659-26-032116 | EDGAR | 17K words |
| 2026-03-19 | 0001104659-26-031780 | EDGAR | — |
| 2025-12-16 | 0001104659-25-121674 | EDGAR | — |
| 2025-12-15 | 0001104659-25-121214 | EDGAR | — |
| 2025-12-15 | 0001104659-25-120915 | EDGAR | — |
| 2025-11-26 | 0001104659-25-116476 | EDGAR | — |
| 2025-11-12 | 0001104659-25-109718 | EDGAR | — |
| 2025-10-07 | 0001104659-25-097591 | EDGAR | — |
| 2025-09-18 | 0001104659-25-090963 | EDGAR | — |
| 2025-08-11 | 0001818382-25-000122 | EDGAR | — |
111 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001818382 |
| Ticker | HUMA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: deec31f7d086063a6ada117939b5a6bc7e460a38eec1e460b951ee83de140ae6
parent: 559e6d7ac9a55987344ffb387c962564ddad565ecb87f47210a35fd097e467b6
content hash: ca4c7bb99d3d9f86d84eedb9d818ae3380c9ff3afedc49580f9fd0d8a7b334d7
signed: 2026-04-13T04:45:34.526Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf